Mineralys Therapeutics (MLYS) Debt Ratio (2026)
Mineralys Therapeutics' Debt Ratio came in at 0.16 for Q3 2026, up 6.7% from the prior quarter.
Powered by 
Analysis
Mineralys Therapeutics (MLYS) Debt Ratio (2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 0.33 |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.23 |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 0.55 |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 0.41 |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 0.08 |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 0.28 |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 0.56 |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 0.51 |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 0.31 |
| 10 | Mineralys Therapeutics | 1.42 Bn | -1.17 Bn | - | 0.16 |
API Access
Mineralys Therapeutics Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=MLYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "MLYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=MLYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();